Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform


Condition: Renal Tumors

Study Type: Observational

Clinical Trials Identifier NCT 8-digits: NCT06868927

Sponsor: IRCCS San Raffaele

Phase:

Eligibility:

  • Age: minimum 18 Years maximum N/A
  • Gender: All

Inclusion Criteria:

  • Presence of a renal mass up to 4 cm
  • Adult > 18 years
  • Candidate to renal surgery
  • Informed consent signed

Exclusion Criteria:

  • Contraindication for MRI

View trial on ClinicalTrials.gov